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EXECUTIVE SUMMARY
Background 
This report provides for the fi rst time comparable global information on the availability of a 
range of resources required for the prevention and treatment of substance use disorders 
by drawing together information from 147 countries that represent 88% of the world 
population. 
A questionnaire was developed to measure a wide range of different resources that benefi t 
the prevention and treatment of substance use disorders at country level, including:
 o administrative and fi nancial resources such as the presence of government units, 
funding and ways of fi nancing treatment and prevention services in countries; 
 o health service resources such as the availability and coverage of different treatment 
services, the presence of pharmacological treatment, the number of beds and the 
length of stay for treatment;
 o human resources such as the involvement of health professionals for the treatment 
of substance use disorders, and the presence of other institutionalized and non-
institutionalized groups providing care for persons with substance use disorders; 
 o policy and legislative resources such as the presence of different policies and 
legislative provisions for prevention and treatment of substance use disorders; 
 o resources for prevention of substance use disorders, such as availability and coverage 
of different prevention services, implementation of screening and brief interventions 
in primary care, and presence of harm reduction programmes;
 o information resources such as knowledge of epidemiological aspects of substance 
use in the country, and knowledge of treatment service delivery. 
Key findings
Chapter 1. Psychoactive substance use: epidemiology and 
burden of disease
 o Point prevalence of alcohol and drug use disorders
Globally, the prevalence of alcohol use disorders is signifi cantly higher than the prevalence 
of drug use disorders. Generally, alcohol and drug use disorders are more common among 
males than among females. 
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 o Psychoactive substance accountable for treatment demand
From the majority of countries in every WHO region1 but one, alcohol was reported to be 
the main psychoactive substance responsible for demand for treatment. In the Region 
of the Americas, treatment demand was chiefl y due to cocaine. 
 o Number of deaths and disability-adjusted life years lost due to psychoactive substance 
use
Globally, some 39 deaths per 100 000 population are attributable to alcohol and illicit 
drug use, out of which 35 deaths are attributable to alcohol use and four are attributable 
to illicit drug use. The use of alcohol and illicit drugs accounts globally for almost 13 
disability-adjusted life years (DALYs) lost per 1000 population. Approximately 11 DALYs 
per 1000 population are lost due to alcohol use, and approximately two DALYs are lost 
due to illicit drug use.
Chapter 2. Health services
 o Government administration and budget for treatment services 
The presence of a government unit or a government offi cial responsible for treatment 
services for substance use disorders was reported by 66.2% of countries. Fewer than 
half of the countries in the survey reported having a specifi c budget line allocated to the 
treatment of substance use disorders. 
 o Financing of treatment services 
Countries identifi ed tax-based funding, out-of-pocket payments and social health insurance 
to be among the foremost methods of funding treatment for alcohol and drug use 
disorders. Africa appears to be the only region in which out-of-pocket payments were 
reported to be the main funding method for alcohol and drug use disorder treatment 
services. 
 o Treatment setting for alcohol and drug use disorders
Nominated focal points in countries reported a variety of treatment settings for persons 
with alcohol and drug use disorders. In the majority of responding countries (39.8%), 
mental health services are the most common treatment setting for alcohol use disorders. 
A higher proportion of countries reported specialized treatment services as the main 
setting for the treatment of drug use disorders (51.5%) compared with treatment of 
alcohol use disorders (34.6%). 
 o Treatment services and coverage of alcohol and drug use disorder treatment
Among different treatment services, inpatient detoxifi cation for alcohol and drug use 
disorders appears to be the most frequently present in countries; it was reported to be 
1 For the list of countries in WHO regions see page 135.
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present in over 90% of countries responding to the survey. However, coverage of the 
population in need with alcohol and drug use disorder treatment services seems to be 
low. For example, in low-income countries the majority of persons with alcohol and drug 
use disorders are not covered by the respective treatment services.
 o Number of beds and length of stay
Among the responding countries, the median number of beds for alcohol and drug use 
disorders was 1.7 per 100 000 population (range of 0–52 beds per 100 000 population). 
The median length of stay for alcohol and drug detoxifi cation was 10.3 days and 14.0 
days respectively. 
 o Care for special populations 
Substance use disorder treatment services for prisoners were reported from 55.9% of 
surveyed countries, followed by substance use disorder treatment services for young 
people (47.6%) and for injecting drug users (40.0%). Specialized substance use disorder 
treatment services for pregnant women and commercial sex workers were reported to be 
present in 31.0% and 25.5% of countries respectively. Approximately 11.0% of countries 
reported having substance use disorder treatment services for indigenous populations. 
Specialized treatment services for persons with drug use disorders and HIV/AIDS were 
reported in 43.2% of countries. Around a quarter of countries (24.6%) reported having 
treatment services for people with both drug use disorders and tuberculosis.
Chapter 3. Pharmacological treatment
 o Policy framework and guidelines for the pharmacological treatment of substance use 
disorders 
Policy documents on the pharmacological treatment of substance use disorders were 
reported by 40.2% of countries, with Europe reporting the highest proportion of countries 
with policy documents on the pharmacological treatment of substance use disorders. 
Guidelines on the pharmacological treatment of substance use disorders were reported 
by approximately half of the surveyed countries (51.8%). 
 o Availability of therapeutic drugs for alcohol and drug use disorders 
With regard to the pharmacological treatment of alcohol withdrawal, benzodiazepines were 
reported to be used for the management of alcohol withdrawal in 90.9% of countries. 
For the treatment of opioid dependence, availability of methadone was reported by 41.6% 
of surveyed countries, buprenorphine by 27.7%, and buprenorphine/naloxone by 20.8% of 
countries. The highest proportion of countries reporting availability of methadone (88.6%), 
buprenorphine (59.1%) and buprenorphine/naloxone (50.0%) was in Europe. 
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 o Administration of opioid agonist pharmacotherapy
Length of treatment with opioid agonist pharmacotherapy was reported to be open-ended 
in the majority of countries, with 74.1% of countries reporting no time limit for opioid 
agonist pharmacotherapy. Over 55% of countries in the survey reported using methadone 
syrup/solution for the treatment of opioid dependence. Approximately 60% of countries in 
the survey reported commencing opioid agonist pharmacotherapy on an outpatient basis. 
 o Supervision and prescription requirements for opioid agonist pharmacotherapy
Supervision of methadone for the treatment of opioid dependence was required by 85.4% 
of countries in the survey. In 60.6% of countries buprenorphine supervision was required, 
while 71.4% of countries required buprenorphine/naloxone supervision.
More than 20% of countries in which methadone is used reported that doctors without 
special training are allowed to prescribe methadone. In approximately 10% of countries 
surveyed, it was reported that non-doctors are given the authority to prescribe opioid 
agonists. 
Chapter 4. Human resources
 o Health professionals 
A variety of health professionals seem to be responsible for the management of alcohol and 
drug use disorders in different countries. The majority of countries reported psychiatrists, 
general practitioners and addictologists/narcologists to be the health professionals chiefl y 
involved in the treatment of alcohol and drug use disorders. 
 o Standards of care and supervision for health professionals
Approximately half of the countries in the survey (47.6%) reported having national 
standards of care for health professionals working with persons with substance use 
disorders. The lowest proportions of countries with standards of care were reported in the 
regions of South-East Asia (20.0%), Africa (20.9%) and the Eastern Mediterranean (28.6%). 
The clinical supervision of nurses was reported in 57.1% of countries in the survey, 
followed by clinical supervision of doctors (52.5% of countries), social workers (44.4% 
of countries) and psychologists (43.5% of countries). Across the regions, Eastern 
Mediterranean and Europe reported having the highest proportions of countries with 
clinical supervision of health professionals.
 o Nongovernmental organizations and self-help groups for substance use disorders
A high proportion of countries have nongovernmental organizations (NGOs) that focus 
on alcohol and drug prevention, with 74.8% and 81.6% of countries reporting to have 
them for alcohol prevention and drug use prevention, respectively. Approximately 70% of 
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surveyed countries reported the presence of NGOs focusing on rehabilitation of alcohol 
and drug use disorders. NGOs involved in treatment of alcohol disorders and drug use 
disorders were reported from 54.5% and 59.9% of countries respectively.
Alcoholics Anonymous was reported to be active in the majority of countries (71.1%). 
Narcotics Anonymous was reported to be active in approximately half of the countries in 
the survey (56.7%), and Cocaine Anonymous in 11.5% of countries.
“Ex-addicts” or “recovering addicts” were reported to provide formal care for persons with 
substance use disorders in 59.9% of countries in the survey, and this situation appears to 
be most common in high-income countries. The highest proportion of traditional healers 
providing care for persons with substance use disorders was reported from low-income 
countries (44.7%). Religious groups or NGOs based on religious groups providing formal 
care for substance use disorders are reported most commonly among countries in the 
higher middle-income group (79.3%).
Chapter 5. Policy and legislation
 o Policy frameworks and special legislative provisions 
The majority of countries in the survey (68.0%) reported having a national substance 
abuse policy, with 100% of high-income countries reporting that they have one. The 
highest proportion of countries in the survey reporting substance abuse policies was in 
the European Region (93.2%). The African Region (32.6%) reported the lowest proportion 
of countries with substance abuse policies.  
Special legislation for the compulsory treatment of substance use disorders was reported 
from 42.5% of countries in the survey. Of these countries, 30% reported having special 
legislation for the compulsory treatment of both alcohol and drug use disorders together.
Government benefi ts for persons with alcohol and drug use disorders were reported 
from 40.6% of countries in the survey. The Western Pacifi c (78.6% for alcohol, 73.3% 
for drugs) and Europe (69.0% for alcohol, 70.5% for drugs) reported having the highest 
proportions of countries providing government benefi ts for persons with alcohol and drug 
use disorders. 
 o The criminal justice system and substance use disorders 
The presence of drug courts was reported in 20.5% of countries. The highest proportion 
of countries with drug courts was in the Eastern Mediterranean Region (38.5%). Africa 
(14.0%) and the Americas (14.3%) had the lowest proportions of countries with drug 
courts. 
Half of the countries in the survey (52.2%) reported having programmes referring 
or diverting clients from the criminal justice system towards treatment. The highest 
proportions of countries in the survey with programmes referring or diverting clients from 
the criminal justice system towards treatment were reported by Europe (66.6%), the 
Western Pacifi c (66.6%), the Eastern Mediterranean (61.6%) and South-East Asia (60.0%).
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Chapter 6. Prevention
 o Administration and budget
In 72.4% of countries in the survey, one or more government units responsible for 
the prevention of substance use disorders were reported. Half of the countries in the 
survey (50.0%) reported having a budget line in the annual budget for the prevention of 
substance use disorders. The lowest proportion of countries reporting budget lines was 
in Africa (30.2%). 
 o Availability and coverage of prevention services 
School-based programmes, community-based programmes, and workplace programmes 
for the prevention of substance use disorders were reported by 77.9%, 68.5% and 58.6% 
of countries respectively. However, coverage of the population in need with school-
based programmes, community-based programmes, and workplace programmes for the 
prevention of substance use disorders appears to be low. For example, over 50% of the 
countries indicated that the coverage of school-based programmes for the prevention of 
substance use disorders would be provided for less than half of the population in need. 
 o Prevention services in special populations and harm reduction 
The most commonly reported prevention programmes were those for children and families 
at risk (45.2% of countries), followed by prevention programmes for prisoners (43.2%), 
for people living with HIV/AIDS (41.1%), for pregnant women (32.2%), for commercial 
sex workers (29.5%) and for minority groups (17.8%). 
The presence of needle/syringe exchange programmes differs within countries. In 41.1% 
of countries, community-based needle/syringe exchange programmes were reported. 
Some 6.6% of countries reported having syringe exchange programmes in prisons.
 o Screening and brief intervention programmes
Screening and brief interventions implemented in primary health care for hazardous and 
harmful alcohol use and for drug use were reported by 47.9% and 46.2% of countries 
respectively. The Americas and the Western Pacifi c reported the highest proportions of 
countries with screening and brief interventions for harmful alcohol use (76.2% and 69.2% 
respectively) and drug use (65.0% and 71.4% respectively). 
 o Groups and agencies involved in prevention of substance use disorders
Different groups and agencies appear to be involved in the prevention of substance use 
disorders in countries. In 78.1% of countries, schools are involved in the prevention of 
substance use disorders, followed by community groups (49.3%) and employers (29.5%). 
The involvement of law enforcement agencies in the prevention of substance use 
disorders was reported by 68.5% of countries. Involvement of international organizations 
in the prevention of substance use disorders was reported by 56.8% of countries, followed 
by the involvement of labour organizations (19.2%).
